Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Change in Inventory: 2019-2025

Historic Change in Inventory for Catalyst Pharmaceuticals (CPRX) over the last 7 years, with Sep 2025 value amounting to $9.1 million.

  • Catalyst Pharmaceuticals' Change in Inventory rose 353.67% to $9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.4 million, marking a year-over-year decrease of 23.57%. This contributed to the annual value of $3.9 million for FY2024, which is 17.77% down from last year.
  • According to the latest figures from Q3 2025, Catalyst Pharmaceuticals' Change in Inventory is $9.1 million, which was up 2,097.14% from -$455,000 recorded in Q2 2025.
  • In the past 5 years, Catalyst Pharmaceuticals' Change in Inventory registered a high of $9.1 million during Q3 2025, and its lowest value of -$1.9 million during Q2 2024.
  • For the 3-year period, Catalyst Pharmaceuticals' Change in Inventory averaged around $1.6 million, with its median value being $237,000 (2025).
  • Examining YoY changes over the last 5 years, Catalyst Pharmaceuticals' Change in Inventory showed a top increase of 2,121.10% in 2023 and a maximum decrease of 1,241.86% in 2023.
  • Quarterly analysis of 5 years shows Catalyst Pharmaceuticals' Change in Inventory stood at $920,000 in 2021, then plummeted by 135.54% to -$327,000 in 2022, then soared by 2,121.10% to $6.6 million in 2023, then tumbled by 107.20% to -$476,000 in 2024, then soared by 353.67% to $9.1 million in 2025.
  • Its Change in Inventory stands at $9.1 million for Q3 2025, versus -$455,000 for Q2 2025 and $237,000 for Q1 2025.